Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/35/96/ba/3596baa9-83b2-ae1f-83d7-75f732b3dc49/mza_14002213919152191084.jpg/600x600bb.jpg
Non-binding Guidance
Ropes & Gray LLP
37 episodes
1 month ago
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.
Show more...
Business News
News,
Government
RSS
All content for Non-binding Guidance is the property of Ropes & Gray LLP and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.
Show more...
Business News
News,
Government
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/35/96/ba/3596baa9-83b2-ae1f-83d7-75f732b3dc49/mza_14002213919152191084.jpg/600x600bb.jpg
Introducing the U.S. Medical Device Recalls Resource Manual
Non-binding Guidance
7 minutes
2 years ago
Introducing the U.S. Medical Device Recalls Resource Manual

Join partners Greg Levine and Josh Oyster from Ropes & Gray’s life sciences regulatory and compliance practice group for a special edition of Non-binding Guidance, a podcast series which focuses on current trends in life sciences regulatory law as well as other important developments affecting the life sciences industry. On this episode, Greg and Josh discuss the publication of Ropes & Gray’s U.S. Medical Device Recalls Resource Manual, a reference tool to guide medical device companies considering, planning, or executing product recalls and other field actions. 

Non-binding Guidance
A Ropes & Gray (RopesTalk) podcast series, focused on current trends in FDA regulatory law, as well as other important developments affecting the life sciences industry.